Top Medical Stocks To Watch Now - June 27th

Hims & Hers Health, UnitedHealth Group, and Eli Lilly and Company are the three Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly traded companies operating in the healthcare and life‐sciences sectors, including pharmaceuticals, biotechnology, medical device manufacturers, and healthcare service providers. Investors buy and sell these stocks to gain exposure to medical innovation, drug development, diagnostic tools, and patient care services. Performance of medical stocks often depends on factors such as regulatory approvals, clinical trial results, patent expirations, and changes in healthcare policy. These companies had the highest dollar trading volume of any Medical stocks within the last several days.

Hims & Hers Health (HIMS)

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

NYSE HIMS traded up $3.78 during trading hours on Friday, hitting $50.06. The company had a trading volume of 59,653,780 shares, compared to its average volume of 23,012,826. The firm has a market cap of $11.21 billion, a P/E ratio of 72.54, a price-to-earnings-growth ratio of 1.56 and a beta of 2.09. Hims & Hers Health has a fifty-two week low of $13.47 and a fifty-two week high of $72.98. The business has a fifty day simple moving average of $49.65 and a 200-day simple moving average of $39.46.

Read Our Latest Research Report on HIMS

UnitedHealth Group (UNH)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Shares of UNH stock traded up $6.75 during trading hours on Friday, reaching $309.37. The stock had a trading volume of 4,945,808 shares, compared to its average volume of 7,407,641. UnitedHealth Group has a twelve month low of $248.88 and a twelve month high of $630.73. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85. The firm has a market capitalization of $280.64 billion, a PE ratio of 12.95, a price-to-earnings-growth ratio of 1.43 and a beta of 0.44. The firm has a 50-day simple moving average of $339.15 and a 200-day simple moving average of $456.28.

Read Our Latest Research Report on UNH

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

Shares of LLY traded down $11.44 during mid-day trading on Friday, reaching $783.68. 1,335,575 shares of the company's stock traded hands, compared to its average volume of 3,664,760. The company has a debt-to-equity ratio of 2.18, a quick ratio of 1.06 and a current ratio of 1.37. The business's 50-day moving average price is $781.50 and its 200-day moving average price is $800.11. The stock has a market capitalization of $742.73 billion, a P/E ratio of 64.03, a price-to-earnings-growth ratio of 1.16 and a beta of 0.40. Eli Lilly and Company has a 12 month low of $677.09 and a 12 month high of $972.53.

Read Our Latest Research Report on LLY

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.